1FM

(3S,5Z,8S,9S,11E)-8,9,16-trihydroxy-14-methoxy-3-methyl-3,4,9,10-tetrahydro-1H-2-benzoxacyclotetradecine-1,7(8H)-dione

Created:	2013-01-16
Last modified:	2024-09-27

Find Related PDB Entry
2 entries where 1FM is found as a standalone ligand1 entries where 1FM is covalently linked to polymer or other heterogen groups

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	48
Chiral Atom Count	3
Bond Count	49
Aromatic Bond Count	6

2D diagram of 1FM

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	(3S,5Z,8S,9S,11E)-8,9,16-trihydroxy-14-methoxy-3-methyl-3,4,9,10-tetrahydro-1H-2-benzoxacyclotetradecine-1,7(8H)-dione
Synonyms	(5Z)-7-Oxozeaenol
Systematic Name (OpenEye OEToolkits)	(2E,5S,6S,8Z,11S)-17-methoxy-11-methyl-5,6,15-tris(oxidanyl)-12-oxabicyclo[12.4.0]octadeca-1(14),2,8,15,17-pentaene-7,13-dione
Formula	C₁₉ H₂₂ O₇
Molecular Weight	362.374
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	O=C1OC(CC=CC(=O)C(O)C(O)CC=Cc2cc(OC)cc(O)c12)C
SMILES	CACTVS	3.370	COc1cc(O)c2C(=O)O[CH](C)CC=CC(=O)[CH](O)[CH](O)CC=Cc2c1
SMILES	OpenEye OEToolkits	1.7.6	CC1CC=CC(=O)C(C(CC=Cc2cc(cc(c2C(=O)O1)O)OC)O)O
Canonical SMILES	CACTVS	3.370	COc1cc(O)c2C(=O)O[C@@H](C)C\C=C/C(=O)[C@@H](O)[C@@H](O)C\C=C\c2c1
Canonical SMILES	OpenEye OEToolkits	1.7.6	C[C@H]1C/C=C\C(=O)[C@H]([C@H](C/C=C/c2cc(cc(c2C(=O)O1)O)OC)O)O
InChI	InChI	1.03	InChI=1S/C19H22O7/c1-11-5-3-7-14(20)18(23)15(21)8-4-6-12-9-13(25-2)10-16(22)17(12)19(24)26-11/h3-4,6-7,9-11,15,18,21-23H,5,8H2,1-2H3/b6-4+,7-3-/t11-,15-,18+/m0/s1
InChIKey	InChI	1.03	NEQZWEXWOFPKOT-BYRRXHGESA-N

Related Resource References

Resource Name	Reference
Pharos	CHEMBL1077979
PubChem	9863776
ChEMBL	CHEMBL1077979
ChEBI	CHEBI:95343, CHEBI:67559

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.